EASL Updates: Intercept Says Biomarker Data Bolster OCA’s Case For Fibrosis Benefit

 
• By Joseph Haas
  
DATA_Puzzle Piece_186976547_1200.jpg
Companies presented new data in NASH and PBC at EASL 2020
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D